Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Femathina studied for endometrial thinning in new phase II trial

April 10, 2007

Proellex improves symptoms associated with uterine fibroids

April 10, 2007

Acomplia approved in Switzerland

April 10, 2007

Recent patents describe new antidiabetic agents

April 5, 2007

Lilly's dual endothelial and hepatic lipase inhibitors modulate HDL cholesterol levels in vivo

April 5, 2007

KV to acquire U.S. marketing rights to EvaMist

April 5, 2007

Janumet receives FDA approval

April 3, 2007

Recent patents report novel therapeutic agents for metabolic disorders

April 3, 2007

Aska licenses rights to JCR's recombinant FSH

April 3, 2007

Structure and biological evaluation of CKD-501 presented at the ACS meeting

April 3, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...